Bioneercorporation

064550 · KOSDAQ · ₩064550 · 바이오니아

₩7,070▲ ₩60 (0.86%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me

Valuation model · Discounted cash flow (DCF)

We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.

Fair value per share

₩6,256

vs the current price (₩7,070)

Enterprise value
₩129B
Equity value
₩161B
WACC
7.3%

Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.

Bear / Base / Bull

Bear
₩1,297
−81.7%
Base
₩6,256
−11.5%
Bull
₩15,328
+116.8%

Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.

Assumptions

Sign in to change the assumptions and see the results update. Sign in

Cycle options

Margin path

Every year uses the cycle-average margin (3.0%).

Revenue growth

  • 14.8%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (14.8% a year, annual reports), fading to 3% by year 5.

  • 11.8%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (14.8% a year, annual reports), fading to 3% by year 5.

  • 8.9%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (14.8% a year, annual reports), fading to 3% by year 5.

  • 5.9%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (14.8% a year, annual reports), fading to 3% by year 5.

  • 3%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (14.8% a year, annual reports), fading to 3% by year 5.

Business

  • 3%

    Operating profit as a share of revenue.

    Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.

  • 27.5%

    Share of operating profit paid as corporate tax.

    Default: Korea's top corporate tax rate (25%) plus 10% local income tax.

  • 2.4%

    The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).

    Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).

  • 3%

    Money spent on factories, equipment, software and other long-term assets (% of revenue).

    Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).

  • 12.9%

    Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.

    Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.

Discount rate

  • 2%

    How fast cash flows keep growing every year after year 5.

    Default: about Korea's long-run inflation plus real growth.

  • 4.03%

    Yield on Korea's 10-year government bond: the return with almost no risk.

    Default: Korea Treasury Bond 10-year yield on 2026-10-27.

  • 0.6

    How much the share moves when the market moves: 1 means just like the market.

    Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.22, adjusted toward 1 and kept between 0.6 and 2.0.

  • 5.5%

    The extra return investors want for owning shares instead of bonds.

    Default: a typical premium for Korean shares.

  • 5.53%

    The interest rate the company would pay to borrow.

    Default: the 10-year yield plus a 1.5% credit spread.

Starting point

Revenue (TTM to H1 2026)
₩346B
Net debt (borrowings and leases − cash and deposits)
−₩38B
+ Stakes and investments
₩7.5B
Associates, long-term financial assets and deposits (book value)
− Minority interests
₩14B
Shares
25,810,291
Share price
₩7,070
Market cap
₩182B

TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.

Past years and projection

Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.

FY2023FY2024FY2025Year 1Year 2Year 3Year 4Year 5
Revenue₩263B₩294B₩330B₩397B₩444B₩483B₩512B₩527B
Growth20.5%11.7%12.3%14.8%11.8%8.9%5.9%3.0%
EBIT₩792M−₩13B₩15B₩12B₩13B₩15B₩15B₩16B
EBIT margin0.3%−4.6%4.6%3.0%3.0%3.0%3.0%3.0%
After-tax EBIT₩574M−₩9.7B₩11B₩8.6B₩9.7B₩11B₩11B₩11B
+ Depreciation———₩9.5B₩11B₩12B₩12B₩13B
− Capital spending₩5.5B₩14B₩7.2B₩12B₩13B₩15B₩15B₩16B
− Working capital−₩15B−₩38B₩11B₩6.6B₩6B₩5.1B₩3.7B₩2B
Free cash flow———−₩350M₩948M₩2.5B₩4.4B₩6.3B
Discount factor———0.9320.8680.8090.7530.702
Present value———−₩326M₩823M₩2B₩3.3B₩4.4B

Terminal value ₩169B, worth ₩119B today: 92% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.

Cross-check: what the market has paid before

For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:

LowTypicalHigh
Price / book (book value ₩7,904 a share)Now 0.89×₩10,2551.30×₩24,7383.13×₩46,3985.87×

Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.

Sensitivity

Fair value per share as two inputs change; the middle is the current case.

WACC ↓ · Terminal growth →1.0%1.5%2.0%2.5%3.0%
6.3%₩6,812₩7,168₩7,605₩8,153₩8,862
6.8%₩6,254₩6,529₩6,860₩7,264₩7,771
7.3%₩5,786₩6,002₩6,256₩6,560₩6,933
7.8%₩5,388₩5,559₩5,757₩5,991₩6,271
8.3%₩5,046₩5,182₩5,338₩5,520₩5,734

Now (TTM)

Market cap
₩182B
Enterprise value
₩142B
P/E
—
P/B
0.9×
P/S
0.5×
EV/EBITDA
—
Dividend yield
0.0%

Over time (at each year end)

20252024202320222021
Price₩12,750₩18,850₩33,300₩29,400₩48,600
Market cap₩329B₩487B₩859B₩759B₩1.3T
P/E———62.8×46.2×
P/B1.6×2.3×3.8×3.2×6.2×
P/S1.0×1.7×3.3×3.5×5.6×
EV/EBITDA—————
Dividend yield0.0%————

Versus similar companies

CompanyP/EP/BP/SEV/EBITDADividend yield
Bioneercorporation—0.9×0.5×—0.0%
Samsung Biologics32.1×7.6×14.0×—0.0%
Celltrion27.8×2.4×8.9×—0.0%
Alteogen78.8×28.4×59.9×—0.1%
Yuhan24.8×2.5×2.6×32.5×0.8%
SK biopharmaceuticals14.6×5.7×6.8×—0.0%
HLB—15.4×54.6×—0.0%
Similar companies (median)27.8×6.7×11.5×32.5×0.0%

Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.

Also known as: Bioneercorporation / 바이오니아 / 064550 / KRX:064550

Source: KRX statistical information